Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons. (NCT06972225) | Clinical Trial Compass
RecruitingNot Applicable
Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.
Canada1,500 participantsStarted 2025-06-10
Plain-language summary
Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults (\>=18 years of age)
* Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
* Identified in the institutional procedure database
Exclusion Criteria:
* Incomplete or non-available data on the post-procedural clinical follow-up
* Procedures where other devices were used in combination with drug-eluting balloons.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this is a retrospective study looking back at patient records rather than testing a new treatment, does participating involve any actual changes to my care, or would it just mean allowing researchers to review my existing medical data?
2This trial is specifically focused on major adverse cardiovascular events in patients treated with drug-eluting balloons for conditions like coronary artery disease, restenosis, or bifurcation disease — do my diagnosis and treatment history match what the researchers are looking for?
3Because this is a retrospective analysis rather than a controlled clinical trial, what can it realistically tell us about the safety or effectiveness of drug-eluting balloons compared to other treatment options like drug-eluting stents?
4If I allow my records to be included in this study, what steps are taken to protect my personal health information, and who would have access to my data?
5Would taking part in this retrospective review have any impact on my current treatment plan or future options, or is it entirely separate from the care I'm already receiving?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.